These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 38113311

  • 1. Long-Term Downregulation of the Sodium Channel Gene Scn8a Is Therapeutic in Mouse Models of SCN8A Epilepsy.
    Hill SF, Yu W, Ziobro J, Chalasani S, Reger F, Meisler MH.
    Ann Neurol; 2024 Apr; 95(4):754-759. PubMed ID: 38113311
    [Abstract] [Full Text] [Related]

  • 2. Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome.
    Lenk GM, Jafar-Nejad P, Hill SF, Huffman LD, Smolen CE, Wagnon JL, Petit H, Yu W, Ziobro J, Bhatia K, Parent J, Giger RJ, Rigo F, Meisler MH.
    Ann Neurol; 2020 Mar; 87(3):339-346. PubMed ID: 31943325
    [Abstract] [Full Text] [Related]

  • 3. Aberrant Sodium Channel Currents and Hyperexcitability of Medial Entorhinal Cortex Neurons in a Mouse Model of SCN8A Encephalopathy.
    Ottolini M, Barker BS, Gaykema RP, Meisler MH, Patel MK.
    J Neurosci; 2017 Aug 09; 37(32):7643-7655. PubMed ID: 28676574
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy.
    Wagnon JL, Korn MJ, Parent R, Tarpey TA, Jones JM, Hammer MF, Murphy GG, Parent JM, Meisler MH.
    Hum Mol Genet; 2015 Jan 15; 24(2):506-15. PubMed ID: 25227913
    [Abstract] [Full Text] [Related]

  • 7. Genetic and clinical features of SCN8A developmental and epileptic encephalopathy.
    Kim HJ, Yang D, Kim SH, Kim B, Kim HD, Lee JS, Choi JR, Lee ST, Kang HC.
    Epilepsy Res; 2019 Dec 15; 158():106222. PubMed ID: 31675620
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin-Positive Interneurons Contribute to Seizures in SCN8A Epileptic Encephalopathy.
    Wengert ER, Miralles RM, Wedgwood KCA, Wagley PK, Strohm SM, Panchal PS, Idrissi AM, Wenker IC, Thompson JA, Gaykema RP, Patel MK.
    J Neurosci; 2021 Nov 03; 41(44):9257-9273. PubMed ID: 34544834
    [Abstract] [Full Text] [Related]

  • 9. NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats.
    Johnson JP, Focken T, Khakh K, Tari PK, Dube C, Goodchild SJ, Andrez JC, Bankar G, Bogucki D, Burford K, Chang E, Chowdhury S, Dean R, de Boer G, Decker S, Dehnhardt C, Feng M, Gong W, Grimwood M, Hasan A, Hussainkhel A, Jia Q, Lee S, Li J, Lin S, Lindgren A, Lofstrand V, Mezeyova J, Namdari R, Nelkenbrecher K, Shuart NG, Sojo L, Sun S, Taron M, Waldbrook M, Weeratunge D, Wesolowski S, Williams A, Wilson M, Xie Z, Yoo R, Young C, Zenova A, Zhang W, Cutts AJ, Sherrington RP, Pimstone SN, Winquist R, Cohen CJ, Empfield JR.
    Elife; 2022 Mar 02; 11():. PubMed ID: 35234610
    [Abstract] [Full Text] [Related]

  • 10. Genetic interaction between Scn8a and potassium channel genes Kcna1 and Kcnq2.
    Hill SF, Ziobro JM, Jafar-Nejad P, Rigo F, Meisler MH.
    Epilepsia; 2022 Oct 02; 63(10):e125-e131. PubMed ID: 35892317
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and genetic spectrum in Chinese children with SCN8A-related disorders.
    Hu C, Luo T, Wang Y.
    Seizure; 2022 Feb 02; 95():38-49. PubMed ID: 34979445
    [Abstract] [Full Text] [Related]

  • 12. SCN8A Epilepsy, Developmental Encephalopathy, and Related Disorders.
    Talwar D, Hammer MF.
    Pediatr Neurol; 2021 Sep 02; 122():76-83. PubMed ID: 34353676
    [Abstract] [Full Text] [Related]

  • 13. Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance.
    Makinson CD, Tanaka BS, Lamar T, Goldin AL, Escayg A.
    Neurobiol Dis; 2014 Aug 02; 68():16-25. PubMed ID: 24704313
    [Abstract] [Full Text] [Related]

  • 14. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS, Tang B, Papale LA, Yu FH, Catterall WA, Escayg A.
    Hum Mol Genet; 2007 Dec 01; 16(23):2892-9. PubMed ID: 17881658
    [Abstract] [Full Text] [Related]

  • 15. Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse.
    Yu W, Hill SF, Xenakis JG, Pardo-Manuel de Villena F, Wagnon JL, Meisler MH.
    Epilepsia; 2020 Dec 01; 61(12):2847-2856. PubMed ID: 33140451
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey.
    Cutts A, Savoie H, Hammer MF, Schreiber J, Grayson C, Luzon C, Butterfield N, Pimstone SN, Aycardi E, Harden C, Yonan C, Jen E, Nguyen T, Carmack T, Haubenberger D.
    Seizure; 2022 Apr 01; 97():50-57. PubMed ID: 35325842
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy.
    Hill SF, Jafar-Nejad P, Rigo F, Meisler MH.
    Front Neurosci; 2023 Apr 01; 17():1282201. PubMed ID: 37901435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.